AstraZeneca says its coronavirus vaccine candidate is 70% effective on average

Drugmaker AstraZeneca announced on Monday that its experimental coronavirus vaccine has shown an average efficacy of 70% in its large scale trials -- the latest of several vaccine trials worldwide to post their results this month. Pročitaj više